MyD88 signalling is critical in the development of pancreatic cancer cachexia

por Zhu, Xinxia, Burfeind, Kevin G., Michaelis, Katherine A., Braun, Theodore P., Olson, Brennan, Pelz, Katherine R., Morgan, Terry K., Marks, Daniel L.
Publicado 2019

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia

por Olson, Brennan, Zhu, Xinxia, Norgard, Mason A., Levasseur, Peter R., Butler, John T., Buenafe, Abigail, Burfeind, Kevin G., Michaelis, Katherine A., Pelz, Katherine R., Mendez, Heike, Edwards, Jared, Krasnow, Stephanie M., Grossberg, Aaron J., Marks, Daniel L.
Publicado 2021

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer

por Michaelis, Katherine A., Norgard, Mason A., Zhu, Xinxia, Levasseur, Peter R., Sivagnanam, Shamilene, Liudahl, Shannon M., Burfeind, Kevin G., Olson, Brennan, Pelz, Katherine R., Angeles Ramos, Diana M., Maurer, H. Carlo, Olive, Kenneth P., Coussens, Lisa M., Morgan, Terry K., Marks, Daniel L.
Publicado 2019

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer

por Michaelis, Katherine A., Norgard, Mason A., Zhu, Xinxia, Levasseur, Peter R., Sivagnanam, Shamilene, Liudahl, Shannon M., Burfeind, Kevin G., Olson, Brennan, Pelz, Katherine R., Ramos, Diana M. Angeles, Maurer, H. Carlo, Olive, Kenneth P., Coussens, Lisa M., Morgan, Terry K., Marks, Daniel L.
Publicado 2019